Literature DB >> 18537459

Fibromyalgia and cognition.

Jennifer M Glass1.   

Abstract

Patients with fibromyalgia frequently complain of cognitive problems or "fibrofog." The existence of these symptoms has been confirmed by studies of the incidence of cognitive problems in fibromyalgia patients and by the results of objective tests of metamemory, working memory, semantic memory, everyday attention, task switching, and selective attention. The results of these tests show that fibromyalgia patients have impairments in working, episodic, and semantic memory that mimic about 20 years of aging. These patients have particular difficulty with memory when tasks are complex and their attention is divided. Cognitive symptoms in these patients may be exacerbated by the presence of depression, anxiety, sleep problems, endocrine disturbances, and pain, but the relationship of these factors to cognitive problems in fibromyalgia patients is unclear. Standardized tests and treatment have not yet been established for cognitive problems in fibromyalgia patients.

Entities:  

Mesh:

Year:  2008        PMID: 18537459

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  33 in total

Review 1.  [Cognitive impairment in patients suffering from fibromyalgia. An underestimated problem].

Authors:  T Schmidt-Wilcke; P Wood; R Lürding
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

2.  Primary Sjogren's syndrome: cognitive symptoms, mood, and cognitive performance.

Authors:  B M Segal; B Pogatchnik; E Holker; H Liu; J Sloan; N Rhodus; K L Moser
Journal:  Acta Neurol Scand       Date:  2011-06-09       Impact factor: 3.209

Review 3.  Neuropsychiatric Disorders as Erratic Attention Regulation - Lessons from Electrophysiology.

Authors:  Goded Shahaf
Journal:  Psychiatr Q       Date:  2019-12

4.  Discrepancies in sleep diary and actigraphy assessments in adults with fibromyalgia: Associations with opioid dose and age.

Authors:  Ashley F Curtis; Mary Beth Miller; Jeff Boissoneault; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae
Journal:  J Sleep Res       Date:  2018-07-31       Impact factor: 3.981

Review 5.  Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.

Authors:  Howard M Kravitz; Robert S Katz
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

6.  Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.

Authors:  Robert H Palmer; Antonia Periclou; Pradeep Banerjee
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

7.  The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia Syndrome.

Authors:  Chad S Boomershine
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

8.  Fibromyalgia and the therapeutic relationship: where uncertainty meets attitude.

Authors:  Sean M Hayes; Genevieve C Myhal; John F Thornton; Monique Camerlain; Cynthia Jamison; Kayla N Cytryn; S Murray
Journal:  Pain Res Manag       Date:  2010 Nov-Dec       Impact factor: 3.037

9.  Role and rationale for the use of milnacipran in the management of fibromyalgia.

Authors:  Jay D Kranzler; R Michael Gendreau
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

10.  Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination.

Authors:  Jose Rodríguez-Andreu; Rosario Ibáñez-Bosch; Amparo Portero-Vázquez; Xavier Masramon; Javier Rejas; Rafael Gálvez
Journal:  BMC Musculoskelet Disord       Date:  2009-12-21       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.